No junk: Long RNA mimics DNA, restrains hormone responses

November 07, 2014

It arises from what scientists previously described as "junk DNA" or "the dark matter of the genome," but this gene is definitely not junk.

The gene GAS5 acts as a brake on steroid hormone receptors, making it a key player in diseases such as hormone-sensitive prostate and breast cancer.

Unlike many genes scientists are familiar with, GAS5 does not encode a protein. It gets transcribed into RNA, like other genes, but with GAS5 the RNA is what's important, not the protein. The RNA accumulates in cells subjected to stress and soaks up steroid hormone receptors, preventing them from binding DNA and turning genes on and off.

Researchers at Emory University School of Medicine have obtained a detailed picture of how the Gas5 RNA interacts with steroid hormone receptors. Their findings show how the Gas5 RNA takes the place of DNA, and give hints as to how it evolved.

The results are scheduled for publication in Nature Communications.

Scientists used to think that much of the genome was "fly-over country": not encoding any protein and not even accessed much by the cell's gene-reading machinery. Recent studies have revealed that a large part of the genome is copied into lincRNAs (long intergenic noncoding RNAs), of which Gas5 is an example.

"There are thousands of long non-coding RNAs that play critical roles in gene regulation, and little data to tell us how they are functioning or where they came from," says lead author graduate student Will Hudson. "We took a deep dive into looking at the interaction of the Gas5 RNA with steroid hormone receptors, and we think this work may serve as a model to understand how lincRNAs interact with other proteins."

Hudson is in the Molecular Systems Pharmacology graduate program at Emory, working with Eric Ortlund, PhD, assistant professor of biochemistry. They and their colleagues probed the interaction of Gas5 RNA with the glucocorticoid receptor, which binds the stress hormone cortisol.

Collaborators at Scripps Research Institute in Florida and Keele University in the UK contributed cellular assays and NMR experiments.

When steroid hormones (examples: cortisol, progesterone, testosterone) are present they bind specific protein receptors and are able to control gene activity by attaching to particular DNA sequences. The Gas5 RNA functions by mimicking those DNA binding sites, competing for steroid receptor proteins within the cell.

"We demonstrated that a slight alteration in Gas5's sequence disrupts its ability to control the growth of prostate cancer cells, for example," Ortlund says. "This is important, because whether the specific sequence of lincRNAs is critical for their function has been an open question."

Their results suggest how genetic variations in Gas5 could account for risk for some forms of cancer. The researchers also examined the Gas5 sequence in various species throughout evolution, and found that the sequence important for regulation of steroid receptors grew out of another genomic sequence important in RNA splicing.
-end-


Emory Health Sciences

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.